Vanguard Global Advisers »

Aligos Therapeutics shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Aligos Therapeutics (ALGS) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Aligos Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aligos Therapeutics held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aligos Therapeutics by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $7.0k 936 7.43

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Aligos Therapeutics

Deep Track Capital
Alyeska Investment Group
Sio Capital Management
Marshall Wace
Bank of America Corporation
Vanguard Group
Vanguard Capital Management
Woodline Partners
SummitTX Capital
Renaissance Technologies
Baker Bros. Advisors
Hillhouse Capital Advisors
Verition Fund Management
Citadel Advisors
LPL Financial

View all funds holding Aligos Therapeutics